Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1461709
Name of medicinal product: Covexin 10
Active substances:
Clostridium
Estonian, English, Latin
ATC code: QI02AB01; QI04AB01
Dosage form: suspension for injection
Route of administration: subcutaneous use
Strengh:  
Amount in package: 50ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For the active immunisation of sheep and cattle against diseases associated with infections caused by Clostridium perfringens type A, C. perfringens type B, C. perfringens type C, C. perfringens type D, Clostridium chauvoei, Clostridium novyi type B, Clostridium septicum, Clostridium sordellii and Clostridium haemolyticum and against tetanus caused by Clostridium tetani. For the passive immunisation of lambs and calves against infections caused by the above mentioned clostridial species (except C. haemolyticum in sheep). Onset of immunity: 2 weeks after the basic vaccination course (as demonstrated by serology only). Duration of active immunity as demonstrated by serology only: Sheep: 12 months against C. perfringens type A, B, C and D, C. novyi type B, C. sordellii, C. tetani < 6 months against C. septicum, C. haemolyticum, C. chauvoei Cattle: 12 months against C. tetani and C. perfringens type D < 12 months against C. perfringens type A, B and C < 6 months against C. novyi type B, C. septicum, C. sordellii, C. haemolyticum, C. chauvoei Additionally, an anamnestic humoral immune response (immunological memory) to all components was demonstrated after antigen stimulation 12 months after the basic vaccination course. Duration of passive immunity as demonstrated by serology only: Lambs: At least 2 weeks for C. septicum and C. chauvoei, at least 8 weeks for C. perfringens type B and C. perfringens type C and at least 12 weeks for C. perfringens type A, C. perfringens type D, C. novyi type B, C. tetani and C. sordellii. No passive immunity was observed for C. haemolyticum. Calves: At least 2 weeks for C. sordellii, and C. haemolyticum, at least 8 weeks for C. septicum and C. chauvoei and at least 12 weeks for C. perfringens type A, C. perfringens type B, C. perfringens type C, C. perfringens type D, C. novyi type B, and C. tetani.
Summary of product characteristics (SPC):  (last updated December 11, 2023)
Package information leaflet (PIL): EST  (last updated December 11, 2023)
Labelling:  (last updated December 11, 2023)
Withdrawal time: 0 päeva
Species: veis, lammas
Last imported to Estonia: September 15, 2023
Marketing authorization holder: Zoetis Belgium 
Marketing authorization number: 1617 
Marketing authorization issued on: August 6, 2010 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Entry/Changing date: October 31, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere